Riverview Trust Co Has $181,000 Stock Position in CME Group Inc. (NASDAQ:CME)

Riverview Trust Co decreased its position in CME Group Inc. (NASDAQ:CME) by 15.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 821 shares of the financial services provider’s stock after selling 152 shares during the period. Riverview Trust Co’s holdings in CME Group were worth $181,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. CVA Family Office LLC boosted its stake in CME Group by 11.8% in the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after purchasing an additional 46 shares during the period. B. Riley Wealth Advisors Inc. boosted its stake in CME Group by 1.3% in the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock worth $782,000 after purchasing an additional 48 shares during the period. Capital Advisors Ltd. LLC boosted its stake in shares of CME Group by 4.3% during the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after buying an additional 48 shares during the last quarter. Lester Murray Antman dba SimplyRich boosted its stake in shares of CME Group by 0.7% during the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after buying an additional 50 shares during the last quarter. Finally, Essex LLC boosted its stake in shares of CME Group by 3.3% during the 1st quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock worth $355,000 after buying an additional 52 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

CME has been the subject of a number of recent research reports. Royal Bank of Canada restated a “sector perform” rating and set a $235.00 price objective on shares of CME Group in a research note on Thursday, October 3rd. Bank of America increased their price objective on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research note on Thursday, October 3rd. Citigroup increased their price objective on shares of CME Group from $240.00 to $250.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. Morgan Stanley increased their price objective on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday. Finally, The Goldman Sachs Group upped their target price on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a report on Thursday, October 3rd. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $220.07.

CME Group Stock Performance

Shares of NASDAQ:CME opened at $228.32 on Friday. The company’s 50 day moving average price is $216.92 and its two-hundred day moving average price is $208.39. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.12. The firm has a market cap of $82.21 billion, a PE ratio of 25.97, a PEG ratio of 7.76 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the prior year, the business posted $2.30 EPS. The business’s revenue was up 12.7% compared to the same quarter last year. Equities research analysts predict that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were given a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.01%. CME Group’s dividend payout ratio is 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.